Latest News for: nthi

Edit

NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt

Nasdaq Globe Newswire 06 Oct 2026
NeOnc’s (NASDAQ. NTHI) investigational brain-cancer programs, NEO100 and NEO212, have upcoming FDA catalysts ... .
  • 1
×